Sue Anschutz-Rodgers Eye Center’s Post

BREAKING: We are thrilled to announce that a research team led by #CUAnschutz will receive up to $46 million in federal funding from the Advanced Research Projects Agency for Health (ARPA-H) to advance pioneering research aimed at curing total blindness through human eye transplantation. Learn more about how this funding could transform the future of sight restoration for the millions of Americans facing blindness and vision loss: https://bit.ly/4i8MeHA

We are excited to share that University of Colorado Anschutz Medical Campus researchers have been awarded up to $46 million for Advanced Research Projects Agency for Health (ARPA-H)'s THEA program, which aims to drive groundbreaking research in curing total blindness through human eye transplantation. CU Innovations is thrilled to be part of this transformative journey and learn more about how this funding could change the future of vision restoration. #cuinnovations #cuanschutz

Heart attack and stroke are the biggest killers in Australia. The University of Queensland's Infensa team hopes to change this with help from an unexpected ally – the venomous Australian funnel-web spider. Heart attack survivors risk developing heart failure, treatable only by heart transplant, but donor hearts are in short supply and often damaged during retrieval. The Infensa team has discovered a molecule that prevents cell death during heart attacks or strokes and protects donor hearts during transplantation.  Their research is advancing to human clinical trials, aiming to develop the first drug for first responders to administer to people experiencing heart attack or stroke. Discover more about this transformative research, a finalist for our #ShapingAustraliaAwards24 Problem Solver category, and cast your vote for your favourite nation shaper! https://ow.ly/7sXV50U7yQA Australian Government Department of Education Jason Clare MP Glenn King Nathan Palpant Infensa Bioscience UQ Health, Medicine and Behavioural Sciences Professor Deborah Terry Paul Bonnington Geoff McColl Melissa Brown Kellie-Ann Robinson Associate Professor Mark Smythe Natalie Saez Dr Aline Dantas de Araujo Dr Han Yang Chiu

"Science can only move forward if we are collaborative," shares Marcel van den Brink, MD, PhD, president, City of Hope Los Angeles and City of Hope National Medical Center and the Deana and Steve Campbell Chief Physician Executive Distinguished Chair in Honor of Alexandra Levine, M.D. The BMT & Cell Therapy Winter Workshop exemplifies the power of collaboration — because science is a team sport, and working together is essential to developing breakthrough treatments that transform patient care. #ASH24

Excited to be at the 17th #CTAD24 in Madrid! As Prof. Jacques Touchon reminded us at the Opening Ceremony, "We have the responsibility, here, to fight against this terrible disease!" This conference is a fantastic opportunity to learn more about cutting-edge research and network with leading researchers, industry experts, and innovators in #Alzheimers. With the aim to impact clinical research and patient care outcomes in Alzheimer's At REGEnLIFE, we are organizing our Scientific Advisory Board here and showcasing our poster LP030, "Emerging non-invasive brain stimulation techniques for Alzheimer's treatment: current state and future directions". CTAD Clinical Trials on Alzheimer's Disease #AlzMoonshot StartUp Health

Advancement in science and medicine, if not shared and discussed, becomes lost in a sea of noise. Bringing together community and academic practitioners to discuss, agree, and dissent, is essential to the advancement of medicine. Here, Dr. Wendel Naumann shares his thoughts on the importance of our PeerTalk method... #endometrialcancer #clincalinsights #sgo #gogfoundation #icgs #womanscancer #gynecologicalcancers #gynonc

The Transforming Transplant strategic initiative, an innovative collaboration between Carnegie Mellon University's Biomedical Engineering and Mayo Clinic, addresses barriers in organ transplantation and accelerates innovation in organ replacement. With focus areas of biofabrication, organ repair, organ monitoring using sensor systems, and artificial intelligence to optimize transplant processes, these leading institutions are working to create real improvements in the access to and effectiveness of organ transplantation. https://lnkd.in/ehvpnxGf

Last week, our Chief Scientific Officer, Steven de Maat, had the privilege of presenting TargED’s latest groundbreaking data at the International Symposium on Neuroprotection and Neurorepair (ISN&N) in Potsdam, Germany. Steven shared insights into our innovative approach to degrading blood clots in both microvascular and macrovascular thrombosis, showcasing how this breakthrough enables us to address and potentially cure many forms of thrombotic diseases. Our cutting-edge research holds significant promise in the treatment of acute ischemic stroke (AIS), where rapid clot degradation can minimize neurological damage and improve patient outcomes. Additionally, it opens new therapeutic possibilities for rare but severe conditions like thrombotic thrombocytopenic purpura (TTP), where targeted clot breakdown could help address the underlying pathology.    We are incredibly proud of our team’s dedication to pushing the boundaries of science and making a meaningful impact in the field of neurorepair. A big thank you to ISN&N for hosting such an inspiring event and providing a platform for collaboration and exchange among global experts. Together, we’re shaping the future of healthcare. #Neuroprotection #Neurorepair #Innovation #Healthcare 

🎶 Unless you've been on a desert island, you've probably heard about Celine Dion's powerful performance at the Paris Olympic Games, her first in four years after battling stiff-person syndrome (SPS). Did you know that CAR T cells might offer hope for this challenging condition? 🌟 A recent case study demonstrated the successful use of anti-CD19 CAR T cells in treating a severe, treatment-refractory case of SPS. This innovative therapy led to significant improvements in mobility and symptom relief, showcasing a promising path forward for patients facing similar challenges. 𝐊𝐞𝐲 𝐓𝐚𝐤𝐞-𝐀𝐰𝐚𝐲𝐬: 📈 𝐒𝐢𝐠𝐧𝐢𝐟𝐢𝐜𝐚𝐧𝐭 𝐜𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐢𝐦𝐩𝐫𝐨𝐯𝐞𝐦𝐞𝐧𝐭𝐬: The patient experienced a substantial reduction in stiffness and a dramatic increase in walking distance. 💊 𝐌𝐚𝐧𝐚𝐠𝐞𝐚𝐛𝐥𝐞 𝐬𝐚𝐟𝐞𝐭𝐲 𝐩𝐫𝐨𝐟𝐢𝐥𝐞: The treatment was well-tolerated, with only low-grade side effects that were effectively managed. 🔬 𝐅𝐮𝐭𝐮𝐫𝐞 𝐩𝐨𝐭𝐞𝐧𝐭𝐢𝐚𝐥: These encouraging results support further exploration of CAR T cell therapy in treating SPS and other neuroimmunological disorders. #SPS #CelineDion #CARTCells #JO2024 #GeneTherapy #CellTherapy #Neuroimmunology #InnovativeTherapy #HealthcareInnovation Simon Faissner, Jeremias Motte , Melissa Sgodzai, MSc., Christian Geis, Aiden Haghikia, Dimitrios Mougiakakos, Dominic Borie, M.D., Ph.D., Roland Schroers and Ralf Gold Ruhr University Bochum, St. Josef-Hospital Klinikum der Ruhr-Universität Bochum, University of Jena, Otto-von-Guericke University Magdeburg, Kyverna Therapeutics, Universitätsklinikum Knappschaftskrankenhaus Bochum GmbH

Longevity Breakthroughs in Cellular Rejuvenation At London Longevity Clinic, we’re leading the charge in cellular rejuvenation science—a revolutionary approach to extending healthspan. The Promise of Cellular Rejuvenation: From senolytics (drugs targeting “zombie” cells) to advanced NAD+ therapies, cellular rejuvenation focuses on repairing damage at the root level. Emerging studies show these interventions can slow aging and reduce chronic disease risk. Cutting-Edge Interventions: *NAD+ Therapy: Boosts mitochondrial function and energy production, slowing cellular aging. *Senolytics: Eliminating senescent cells reduces inflammation and promotes tissue repair. *Stem Cell Therapy: Regenerates damaged tissues and supports long-term vitality. At London Longevity Clinic, we’re committed to bringing these revolutionary therapies to you. Stay tuned as we unveil the future of longevity science. #rejuvenation #healthspan #longevity